Beijing Zhongshuo Pharmaceutical Technology Development Co.,Ltd (BEIJING Zhongshuo) is a fast developing joint-stock enterprise, formerly known as Pharmaceutical Development Dept. of CNPIC (China National Pharmaceutical Industry Corp.).
BEIJING Zhongshuo focus on the R&D, manufacture and exporting of APIs (Emphasize particularly on Oncology, Nucleotide, Immunology, Cardiovascular, Neurology etc) and associated pharmaceutical intermediates.

Entecavir is indicated for treatment of chronic hepatitis B infection in adults with active viral replication and who show elevations in ALT or AST (aminotransferases) or histologically active disease (fibrosis or cirrhosis).
CAS: 142217-69-4
Molecular formula: C12H15N5O3. H2O
Appearance: Almost white or white powder
Purity: Not less than 99.7%
EE value: Not less than 99.5%
Melting point: Not less than 220
Specific rotation: +32. 0~ +36. 0
Loss on drying: Not more than 0. 5%
Heavy metals: Not more than 20ppm
Residue on ignition: Not more than 0. 1%
Package: Aluminum foil bag
If you have any demand,pls contact with us by zspharma at hotmail dot com. Regards,Judy Niu